In the new book series ‘ESASO Course Series’, the essentials of the courses of the European School for Advanced Studies in Ophthalmology (ESASO) are made available to interested ophthalmologists, optometrists, technicians and residents all over the world.
Month: June 2012
FDA Actions in Brief May 2012
Recent FDA Approvals (through May 2012) related to (Meda, Novo Nordisk, Janssen, Vivus, Clinigen,
GlaxoSmithKline, Stride Arcolab)
Infliximab reduces uveoretinitis in Behcet disease
NEW YORK (Reuters Health) – Infliximab is safe and effective for treating uveoretinitis in Behcet
disease, a new multi-center study shows.